Search research articles
Contact Us
Filters
Showing results (331-340 of 361) with videos related to
Page
of 37
Sort By:
European Urology
|
April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer
William S Chen, Rahul Aggarwal, Li Zhang, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
European Urology Oncology
|
July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer
Soumyajit Roy, Yilun Sun, James A Eastham, et al.
Nature Genetics
|
July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2013
Penile cancer: Clinical Practice Guidelines in Oncology
Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2013
Bladder cancer
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J Alumkal, Duanchen Sun, Eric Lu, et al.
NPJ Precision Oncology
|
July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer
Anbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 361) with videos related to
Sort By:
Page
of 37
European Urology
|
April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer
William S Chen, Rahul Aggarwal, Li Zhang, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
European Urology Oncology
|
July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer
Soumyajit Roy, Yilun Sun, James A Eastham, et al.
Nature Genetics
|
July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2013
Penile cancer: Clinical Practice Guidelines in Oncology
Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2013
Bladder cancer
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J Alumkal, Duanchen Sun, Eric Lu, et al.
NPJ Precision Oncology
|
July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer
Anbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.
Page
of 37